Connection

SANJAY MATHEW to Drug Resistance

This is a "connection" page, showing publications SANJAY MATHEW has written about Drug Resistance.
Connection Strength

0.551
  1. Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder. Biol Psychiatry. 2009 May 01; 65(9):792-800.
    View in: PubMed
    Score: 0.298
  2. Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression. Biol Psychiatry. 2009 Sep 01; 66(5):522-6.
    View in: PubMed
    Score: 0.078
  3. Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial. Int J Neuropsychopharmacol. 2010 Feb; 13(1):71-82.
    View in: PubMed
    Score: 0.076
  4. Treatment-resistant depression: recent developments and future directions. Depress Anxiety. 2008; 25(12):989-92.
    View in: PubMed
    Score: 0.070
  5. The promise of ketamine for treatment-resistant depression: current evidence and future directions. Ann N Y Acad Sci. 2015 May; 1345:47-58.
    View in: PubMed
    Score: 0.029
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.